Cargando…

Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis

African children are at risk of malaria and malnutrition. We quantified relationships between malaria and malnutrition among young Ugandan children in a high malaria transmission region. Data were used from a randomized controlled trial where Ugandan HIV‐unexposed (n = 393) and HIV‐exposed (n = 186)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Ali Mohamed, Wallender, Erika, Hughes, Emma, Dorsey, Grant, Savic, Radojka M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196432/ https://www.ncbi.nlm.nih.gov/pubmed/36919202 http://dx.doi.org/10.1002/psp4.12892

Ejemplares similares

Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children
por: Wallender, Erika, et al.
Publicado: (2021)

Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations
por: Hughes, Emma, et al.
Publicado: (2021)

The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study
por: Arinaitwe, Emmanuel, et al.
Publicado: (2012)

Response to “Quantitative Clinical Pharmacology INPUT to SARS‐CoV‐2 Therapeutics Should be Based on Robust Data”
por: Garcia‐Cremades, Maria, et al.
Publicado: (2020)

Factors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey
por: Osterbauer, Beth, et al.
Publicado: (2012)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
por: Tchaparian, Eskouhie, et al.
Publicado: (2016)

Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment
por: Davis, Jennifer C, et al.
Publicado: (2006)

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults
por: Byakika-Kibwika, Pauline, et al.
Publicado: (2012)

Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing
por: Garcia‐Cremades, Maria, et al.
Publicado: (2020)

Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children
por: Sundell, Kerstin, et al.
Publicado: (2015)

Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children
por: Njama-Meya, Denise, et al.
Publicado: (2007)

Protective Efficacy and Safety of Three Antimalarial Regimens for the Prevention of Malaria in Young Ugandan Children: A Randomized Controlled Trial
por: Bigira, Victor, et al.
Publicado: (2014)

Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children
por: Jensen, Trevor P, et al.
Publicado: (2009)

Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children
por: Boivin, Michael J., et al.
Publicado: (2016)

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
por: Maiteki-Sebuguzi, Catherine, et al.
Publicado: (2008)

Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting
por: Kakuru, Abel, et al.
Publicado: (2016)

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens
por: Kapisi, James, et al.
Publicado: (2015)

Generation of a malaria negative Ugandan birth weight standard for the diagnosis of small for gestational age
por: Zakama, Arthurine K., et al.
Publicado: (2020)

Efficacy, Safety, and Tolerability of Three Regimens for Prevention of Malaria: A Randomized, Placebo-Controlled Trial in Ugandan Schoolchildren
por: Nankabirwa, Joaniter, et al.
Publicado: (2010)

Marked reduction in antibiotic usage following intensive malaria control in a cohort of Ugandan children
por: Krezanoski, Paul J., et al.
Publicado: (2021)

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial
por: Achan, Jane, et al.
Publicado: (2009)

Incidence of Malaria and Efficacy of Combination Antimalarial Therapies over 4 Years in an Urban Cohort of Ugandan Children
por: Clark, Tamara D., et al.
Publicado: (2010)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
por: Chotsiri, Palang, et al.
Publicado: (2019)

Impact of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren: A Randomized, Placebo-Controlled Trial
por: Nankabirwa, Joaniter I., et al.
Publicado: (2014)

A Mechanistic In Vivo/Ex Vivo Pharmacokinetic‐Pharmacodynamic Model of Tenofovir for HIV Prevention
por: Jayachandran, Priya, et al.
Publicado: (2021)

Perennial malaria chemoprevention with and without malaria vaccination to reduce malaria burden in young children: a modelling analysis
por: Runge, Manuela, et al.
Publicado: (2023)

Rapid improvements to rural Ugandan housing and their association with malaria from intense to reduced transmission: a cohort study
por: Rek, John C, et al.
Publicado: (2018)

Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance
por: Gasasira, Anne F, et al.
Publicado: (2010)

Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
por: Muhindo, Mary K, et al.
Publicado: (2014)

Seasonal malaria chemoprevention packaged with malnutrition prevention in northern Nigeria: A pragmatic trial (SMAMP study) with nested case-control
por: Ward, Abigail, et al.
Publicado: (2019)

Chemoprevention for the Populations of Malaria Endemic Africa
por: Greenwood, Brian, et al.
Publicado: (2022)

Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
por: Vora, Bianca, et al.
Publicado: (2021)

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity
por: Tukwasibwe, Stephen, et al.
Publicado: (2021)

Longitudinal analysis of the capacities of community health workers mobilized for seasonal malaria chemoprevention in Burkina Faso
por: Bicaba, Abel, et al.
Publicado: (2020)

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
por: Coldiron, Matthew E., et al.
Publicado: (2021)

Seasonal Malaria Chemoprevention: An Evolving Research Paradigm
por: Snow, Robert W.
Publicado: (2016)

Seasonal malaria chemoprevention: successes and missed opportunities
por: Coldiron, Matthew E., et al.
Publicado: (2017)

Evaluation of pilot implementation of seasonal malaria chemoprevention on morbidity in young children in Northern Sahelian Ghana
por: Ansah, Patrick O., et al.
Publicado: (2021)

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

A proposed method of grading malaria chemoprevention efficacy
por: White, N J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ca8ele9ceseav4ej9gt2ego62